Warner Chilcott to Present at the 31st Annual J.P. Morgan Healthcare Conference DUBLIN, Ireland, Jan. 2, 2013 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that Roger Boissonneault, President and Chief Executive Officer, and Paul Herendeen, Executive Vice President and Chief Financial Officer, are scheduled to speak at the 31^st Annual J.P. Morgan Healthcare Conference on Tuesday, January 8th at 7:30 a.m. PST (10:30 a.m. EST). The presentation will be simultaneously webcast at http://ir.wcrx.com/events.cfm, with an archived replay of the webcast available shortly thereafter at http://ir.wcrx.com/events.cfm. The Company Warner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare, gastroenterology, urology and dermatology segments of the branded pharmaceuticals market, primarily in North America. We are a fully integrated company with internal resources dedicated to the development, manufacture and promotion of our products. WCRX-G CONTACT: Rochelle Fuhrmann Investor Relations 973-442-3281 firstname.lastname@example.org Warner Chilcott Logo
Warner Chilcott to Present at the 31st Annual J.P. Morgan Healthcare Conference
Press spacebar to pause and continue. Press esc to stop.